Transforming Cancer Treatment with Innovative Therapies

Founded by

Bio

Biopharma

Pre-seed

Modulari-T is a groundbreaking pre-seed venture in the Bio sector founded by David Cotnoir-White, Stephanie Mok, and Étienne Gagnon. This visionary team is developing transformative solutions in the biopharma space with potential to reshape cancer treatment approaches.

‍

The Innovation: MARC Platform

Modulari-T has developed the MARC Platform, a revolutionary biochemical design for CAR-T therapies that addresses critical limitations in current treatment options. Their innovative approach:

Overcomes significant safety concerns associated with existing therapies
Dramatically reduces the high costs of current cancer treatments
Enhances both efficacy and safety profiles
Aims to position CAR-T therapy as a primary cancer treatment
Could significantly reduce reliance on traditional chemotherapy

‍

Strategic Growth and Development

The company is moving forward with ambitious plans for advancement and validation:

Currently securing a $3 million investment to fuel their next phase
Implementing a five-year roadmap focused on advancing their approach through:
- Rigorous preclinical experiments
- Comprehensive clinical trials
- Regulatory pathway development

‍

Potential Healthcare Impact

If successful, Modulari-T's technology could fundamentally transform:

Standard cancer treatment protocols
Patient outcomes and quality of life
Overall healthcare costs associated with cancer care

‍

Contributing to Montreal's Biotech Renaissance

"BioTechnology is really picking up in Montreal right now, so there's going to be a lot of demand to build a network of founders. We're just at the beginning of a wave, and I hope it's gonna become a tidal wave." — David Cotnoir-White, Co-founder, Modulari-T

‍

Pioneering the Future of Cancer Treatment

Modulari-T exemplifies how District 3's ecosystem supports ventures at the cutting edge of biomedical innovation. By developing next-generation cell and gene therapies, they're working to create more effective, accessible cancer treatments while contributing to Montreal's emergence as a biotech hub. Their work demonstrates the tremendous potential of combining scientific excellence with entrepreneurial vision to address one of healthcare's most significant challenges.

stories

We’re surrounded by inspiring people, all driven by a passion to make a difference. Meet the founders, from local to global, whose projects are creating meaningful change.

all stories

UbiSim

Transforming Nursing Training with Immersive VR Solutions

UbiSim's VR platform enhances nursing training, scaling simulations without extra resources and revolutionizing healthcare education.

Freshr

Pioneering Sustainable Packaging for a Zero-Food Waste Future

Freshr Technologies develops compostable packaging that extends seafood shelf life, reducing plastic waste and supporting sustainability.

CANN Forecast

Enhancing Public Health Through Smart Water Management

CANN Forecast empowers municipalities with AI to improve water quality and infrastructure, addressing crises and enhancing public health.

Gray Oncology

Revolutionizing Cancer Care Efficiency and Patient Experience with AI

Gray Oncology optimizes cancer treatment flow, reduces staff workload, and enhances patient experience using AI and operations research.

Cura Therapeutics

The next wave of immunomodulating therapies

CURA's fusion protein reactivates the immune response against cancer, boosting T, NK, and B cells while blocking tumor blood supply.

Hyasynth

Improving the lives of people with neurological health conditions

Hyasynth uses industrial fermentation to supply millions of people with therapeutics

GC LipidTech

Reducing Overfishing and Preserving Marine Biodiversity with Sustainable Microalgae Solutions

GC LipidTech develops engineered microalgae strains to provide sustainable alternatives to fishmeal, supporting more eco-friendly aquaculture and marine biodiversity preservation.

Molecular Forecaster

Accelerating Drug Development Through Predictive Technology

Molecular Forecaster revolutionizes drug discovery with user-friendly predictive software, speeding up preclinical stages and reducing costs, enabling faster access to treatments. District 3 supports biopharma innovation for a healthier future.

Modulari-T

Transforming Cancer Treatment with Innovative Therapies

Modulari-T is revolutionizing cancer treatment with a new CAR-T approach, reducing costs, improving safety and efficacy, and offering better outcomes for patients. This innovation could change how we approach cancer treatment globally.

Komino

Social change through organizing group action

Empowering communities with a platform to help individuals create their own impact.

Cedulify

Transforming Well-being Through Mindful Innovation

Cedulify, an app focused on improving mental wellness through mindfulness, harmony, and connection, is redefining success by addressing burnout and life balance. Created by Anne-Pascale Ménard, it offers holistic tools to promote a mindful and fulfilling life.

Ozex

Supporting New Parents Through Technology

Rediscovering intimacy after having a baby with a mobile app that offers self-help tools to assist new parents.

Concordia University is located on unceded Indigenous lands. The Kanien’kehá:ka Nation is recognized as the custodians of the lands and waters on which we gather today. Tiohtià:ke/Montréal is historically known as a gathering place for many First Nations. Today, it is home to a diverse population of Indigenous and other peoples. We respect the continued connections with the past, present and future in our ongoing relationships with Indigenous and other peoples within the Montreal community.